logo
Select company
Select metric
$ -13.46MConsolidated Income
VS
Market
33
Sector
62
Industry
76
History
67
$ 0.74Close
$ 0.68 - $ 4.73 52-Week Range
Ticker Information

Ticker

KTTA

Company Name

PASITHEA THERAPEUTICS CORP

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

PASITHEA THERAPEUTICS CORP - Consolidated Income Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

KTTA - Cons. Inc. Historical data
DateConsolidated Income
6/30/2025$ -13.46M
3/31/2025$ -13.61M
12/31/2024$ -13.9M
9/30/2024$ -15.78M
6/30/2024$ -16.39M
3/31/2024$ -16.28M
12/31/2023$ -15.96M
9/30/2023$ -16.03M
6/30/2023$ -17M
3/31/2023$ -15.9M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • PASITHEA THERAPEUTICS CORP's latest trailing twelve months (TTM) Cons. Inc. stands at $ -40.98K.
  • Over the past 5 years, PASITHEA THERAPEUTICS CORP's average Cons. Inc. has been $ -11.69M.
  • The median Cons. Inc. for PASITHEA THERAPEUTICS CORP during this period was $ -13.92M
  • PASITHEA THERAPEUTICS CORP reached its highest Cons. Inc. over the past 5 years at $ -40.98K.
  • The lowest Cons. Inc. recorded by PASITHEA THERAPEUTICS CORP in the same timeframe $ -17M

Similar metrics to Cons. Inc.:

Definition of Consolidated Income

[Income Statement] The portion of profit or loss for the period; net of income taxes; which is attributable to the consolidated entity; before the deduction of [NetIncNCI].

KTTA - Consolidated Income, Last 5 years

$ -17M

Minimum

Jun 30, 2023

$ -40.98K

Maximum

Dec 31, 2020

$ -11.69M

Average

$ -13.92M

Median

Cons. Inc. Benchmark Analysis

 The chart above depicts the distribution of Cons. Inc. for companies in the Total Stock Market. The average Cons. Inc. of the companies is $ 12.21M with a standard deviation of $ 116.71M.
The following table provides additional summary stats:
Cons. Inc. in the Market:
filtered constituents3.36K
min$ -363.1M
max$ 378M
average$ 12.21M
median$ -2.05M
std$ 116.71M